Showing 36,888 results

Side effects

IAS: Aging with HIV - are cancer, heart disease, dementia the new challenges?

News
30 July 2007
Starting treatment

IAS: Pendulum swinging towards early treatment as burden of pre-AIDS illness recognised

News
27 July 2007
Side effects

IAS: Roche admits long-standing low-level contamination of nelfinavir

News
26 July 2007
Starting treatment

IAS: Truvada more effective than Kivexa due to drop-outs related to abacavir hypersensitivity

News
26 July 2007
HIV treatment

IAS: Early treatment of HIV-infected infants with ART significantly reduces mortality

News
25 July 2007
Transmission & prevention

IAS: Cellulose sulphate microbicide fails to prevent vaginal HIV transmission – and may even increase risk

News
25 July 2007
Transmission & prevention

IAS: Circumcision may be acceptable to some gay men, but study says no value for HIV prevention

News
25 July 2007
Testing & health monitoring

IAS: Screening for B*5701 reduces abacavir hypersensitivity incidence to zero

News
25 July 2007
Circumcision

IAS: Models predict costs and benefits of circumcision programmes

News
25 July 2007
Circumcision

IAS: Penile washing after sex not a substitute for circumcision

News
25 July 2007
Starting treatment

IAS: Regular dietician consultation effective at preventing HAART-associated dyslipidaemia

News
25 July 2007
Side effects

IAS: Cardiovascular disease and diabetes increasing as causes of death for people with HIV in Brazil

News
25 July 2007
Circumcision

IAS: Lack of data on men with weak immune systems weakens study comparing safety of circumcision in HIV-positive and HIV-negative men

News
25 July 2007
Starting treatment

IAS: Maraviroc slightly less effective but more tolerable in treatment-naive patients

News
25 July 2007
Pregnancy, children & young people

IAS: Low rates of HIV transmission in breastfeeding women on ART

News
24 July 2007
Treatment interruptions

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

News
24 July 2007
Starting treatment

IAS: Integrase inhibitor raltegravir (MK-0518) potent, durable and more tolerable than efavirenz in treatment-naive at 48 weeks

News
24 July 2007
Changing treatment

IAS: Regular viral load testing essential for patients in resource limited settings on NNRTIs, says US resistance expert

News
24 July 2007
Transmission & prevention

IAS: Hepatitis C clusters reveal international transmission among HIV-positive gay men

News
24 July 2007
New & experimental HIV treatments

IAS: Novel once-daily CCR5 antagonist, INC9471, appears potent, well tolerated after 14 days monotherapy

News
24 July 2007
Sexually transmitted infections tests & treatment

IAS: Aciclovir treatment doesn't significantly reduce HIV or HSV-2 shedding in genital secretions

News
24 July 2007
New & experimental HIV treatments

IAS: Vicriviroc still effective at 48 weeks in treatment-experienced, but relationship with cancer remains uncertain

News
24 July 2007
TB treatment

IAS: Studies present reassuring data on the use of ART in patients on TB treatment

News
23 July 2007
TB treatment

IAS: Botswanan study finds low concentrations of TB drugs common in HIV-positives, predict TB treatment failure

News
23 July 2007